VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,229,660 | -9.6% | 342,983 | +1.1% | 0.40% | -5.2% |
| Q2 2023 | $10,212,485 | -6.2% | 339,173 | +0.8% | 0.43% | -12.9% |
| Q1 2023 | $10,882,396 | -13.5% | 336,396 | -23.4% | 0.49% | -17.4% |
| Q4 2022 | $12,585,223 | +83.8% | 439,122 | +54.7% | 0.59% | +65.4% |
| Q3 2022 | $6,847,000 | -12.6% | 283,873 | -0.7% | 0.36% | -12.0% |
| Q2 2022 | $7,831,000 | -19.7% | 286,005 | +12.5% | 0.41% | +2.5% |
| Q1 2022 | $9,749,000 | -16.0% | 254,207 | -29.9% | 0.40% | -14.6% |
| Q4 2021 | $11,610,000 | +10.9% | 362,467 | +2.0% | 0.46% | -1.7% |
| Q3 2021 | $10,473,000 | -11.4% | 355,375 | +2.1% | 0.47% | -16.3% |
| Q2 2021 | $11,825,000 | +7.6% | 348,000 | +2.9% | 0.56% | +0.2% |
| Q1 2021 | $10,994,000 | -3.2% | 338,275 | +7.3% | 0.56% | -15.1% |
| Q4 2020 | $11,353,000 | -3.2% | 315,190 | +5.3% | 0.66% | -18.0% |
| Q3 2020 | $11,726,000 | -23.7% | 299,430 | -28.6% | 0.81% | -30.5% |
| Q2 2020 | $15,374,000 | +44.8% | 419,135 | -9.0% | 1.16% | +17.6% |
| Q1 2020 | $10,615,000 | +37.8% | 460,715 | +75.2% | 0.99% | +54.6% |
| Q4 2019 | $7,701,000 | +13.3% | 263,010 | +3.4% | 0.64% | +1.1% |
| Q3 2019 | $6,796,000 | -4.3% | 254,450 | -8.4% | 0.63% | -6.4% |
| Q2 2019 | $7,098,000 | +10.1% | 277,715 | -3.5% | 0.68% | +4.6% |
| Q1 2019 | $6,449,000 | +5.3% | 287,650 | -0.9% | 0.65% | +0.8% |
| Q4 2018 | $6,124,000 | +14.2% | 290,385 | +0.3% | 0.64% | +35.4% |
| Q3 2018 | $5,361,000 | -16.4% | 289,458 | +0.7% | 0.47% | -21.3% |
| Q2 2018 | $6,416,000 | -0.9% | 287,578 | -2.3% | 0.60% | -3.2% |
| Q1 2018 | $6,473,000 | -1.8% | 294,478 | +3.9% | 0.62% | -6.7% |
| Q4 2017 | $6,589,000 | -0.3% | 283,503 | -1.6% | 0.67% | -13.7% |
| Q3 2017 | $6,612,000 | +12.5% | 287,993 | +8.2% | 0.77% | -18.4% |
| Q2 2017 | $5,876,000 | +9.5% | 266,120 | +13.1% | 0.95% | -15.3% |
| Q1 2017 | $5,368,000 | +6.0% | 235,365 | -2.8% | 1.12% | +14.3% |
| Q4 2016 | $5,065,000 | -20.9% | 242,115 | -0.1% | 0.98% | -22.4% |
| Q3 2016 | $6,404,000 | -6.0% | 242,327 | -1.4% | 1.26% | -14.8% |
| Q2 2016 | $6,812,000 | – | 245,825 | – | 1.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |